🇺🇸 FDA
Patent

US 6066623

Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines

expired A61KA61K2039/53A61K39/00

Quick answer

US patent 6066623 (Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines) held by United States of America as represented by the Secretary of the Air Force expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/53, A61K39/00